<?xml version="1.0" encoding="UTF-8"?>
<p id="p0155">Currently, the US CDC recommended strategy for identifying individuals with COVID-19 is to test respiratory samples to diagnose the presence of one or several specific nucleic acid targets for SARS-CoV-2 [
 <xref rid="bib77" ref-type="bibr">77</xref>]. Nasopharyngeal samples are the first choice for swab-based SARS-CoV-2 testing, but samples of the middle turbinate, oropharynx or anterior nostrils are also acceptable [
 <xref rid="bib78" ref-type="bibr">78</xref>].
</p>
